Domenico Ribatti
University of Bari
965 Papers
6.1K Citations
Domenico Ribatti is an academic researcher from University of Bari. The author has contributed to research in topics: Angiogenesis & Biology. The author has an hindex of 96, co-authored 913 publications. Previous affiliations of Domenico Ribatti include University of Genoa & National Institutes of Health.
Chat about Author
Papers
Anti-angiogenesis in neuroblastoma.
TL;DR: The major goal is to establish if inhibition of angiogenesis is a realistic therapeutic strategy for inhibiting tumour cell dissemination and the formation of metastasis in neuroblastoma.
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with progression in human neuroblastoma
Domenico Ribatti,Giammarco Surico,Angelo Vacca,F. De Leonardis,Gaetano Lastilla,Paolo G. Montaldo,N. Rigillo,Mirco Ponzoni +7 more
TL;DR: In situ data suggest that angiogenesis and degradation of extracellular matrix occur simultaneously with NB tumor progression, and the extent of angiogenic and the expression of the MMP-2 and MMP9 mRNA were upregulated in advancing stages.
The mast cell: an evolutionary perspective.
TL;DR: The origin of MCs is probably to be found in a leukocyte ancestor operating in the context of a primitive local innate immunity and involved in phagocytic and killing activity against pathogens in the Cambrian era, some 550 million years ago.
Calbindin‐D28K Immunoreactivity in the Human Cerebellar Cortex
Paolo Flace,Loredana Lorusso,Giuliana Laiso,Anna Rizzi,Raffaele Cagiano,Beatrice Nico,Domenico Ribatti,Glauco Ambrosi,Vincenzo Benagiano +8 more
TL;DR: It is reported that CB is expressed by different neuron types, both inhibitory (GABAergic) and excitatory (glutamatergic), involved in both intrinsic and extrinsic circuits of the human cerebellar cortex.
Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.
TL;DR: Angiogenesis, that supplies several trophic factors, should be promoted in therapeutic neuroregeneration efforts to combat the progressive, degenerative phase of MS.